Wu R-S, Qiu E-H, Zhu J-J, Wang J-R, Lin H-L
Department of Otolaryngology, the 2nd Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8240. doi: 10.26355/eurrev_202008_22580.
The article "MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway, by R.-S. Wu, E.-H. Qiu, J.-J. Zhu, J.-R. Wang, H.-L. Lin, published in Eur Rev Med Pharmacol Sci 2018; 22(1): 150-157-DOI: 10.26355/eurrev_201801_14112-PMID: 29364482" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14112.
吴R.-S.、邱E.-H.、朱J.-J.、王J.-R.、林H.-L.发表于《欧洲医学与药理学评论》2018年；22(1): 150 - 157 - DOI: 10.26355/eurrev_201801_14112 - PMID: 29364482的文章《MiR - 101通过抑制Ras/Raf/MEK/ERK信号通路促进鼻咽癌细胞凋亡》已被作者撤回。出版方对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/14112 。
